May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Function of Connective Tissue Growth Factor (CTGF) that Interacts With TGF-β in Human Corneal Fibroblasts
Author Affiliations & Notes
  • A. Kodama
    Kinki University School of Medicine, Osaka-sayama, Japan
    Ophthalmology,
  • K. Sugioka
    Kinki University School of Medicine, Osaka-sayama, Japan
    Ophthalmology,
  • H. Mishima
    Ophthalmology, Kinki University School of Medicine, Nara Hospital, Nara, Japan
  • K. Yoshida
    Kinki University School of Medicine, Osaka-sayama, Japan
    Biochemistry,
  • Y. Shimomura
    Kinki University School of Medicine, Osaka-sayama, Japan
    Ophthalmology,
  • Footnotes
    Commercial Relationships  A. Kodama, None; K. Sugioka, None; H. Mishima, None; K. Yoshida, None; Y. Shimomura, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 4820. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Kodama, K. Sugioka, H. Mishima, K. Yoshida, Y. Shimomura; Function of Connective Tissue Growth Factor (CTGF) that Interacts With TGF-β in Human Corneal Fibroblasts. Invest. Ophthalmol. Vis. Sci. 2008;49(13):4820.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Connective tissue growth factor (CTGF) is one of the downstream mediators of TGF-βthat acts to maintain tissue fibrosis. In this study, to determine the function of CTGF in corneal fibroblasts in vitro, we investigated the effects of CTGF on the expression of α-smooth muscle actin (α-SMA) and fibronectin production, as well as its possible influence on the collagen gel contraction by corneal fibroblasts.

Methods: : Corneal fibroblasts from human donors were treated with TGF-β, CTGF, or a combination of both for 48 hours. First, the fibroblasts treated with TGF-βwere evaluated by western blot analysis to examine the effect of TGF-β on CTGF induction. Secondly, the effects of TGF-β, CTGF, and their combination on fibronectin production and on the expression of α-SMA in the corneal fibroblasts were assessed by western blot analysis. Thirdly, the corneal fibroblasts were embedded in a collagen gel and cultured with various concentrations of TGF-β, CTGF, or their combination. The diameters of the gels at specified time points were measured to estimate the collagen gel contraction by the corneal fibroblasts.

Results: : The addition of TGF-β to the corneal fibroblasts elicited CTGF induction in a dose-dependent manner. Regarding fibronectin production, the corneal fibroblasts with the combination of TGF-β and CTGF showed more effective results than those with TGF-β or CTGF alone. On the other hand, no difference in α-SMA expression was seen between the fibroblasts with CTGF alone and those with the combination. In the collagen gel with TGF-β, the diameter of the gel decreased with the concentration of TGF-β in a dose-dependent manner, while no difference in the gel diameter was seen that with the combination.

Conclusions: : In a dose-dependant manner, CTGF in combination with TGF-β effectively facilitates TGF-β-induced fibronectin production in corneal fibroblasts. This study suggested that CTGF could have modified the action of TGF-β on corneal fibroblasts and played an important role in corneal wound healing.

Keywords: cornea: stroma and keratocytes • wound healing • extracellular matrix 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×